Exhibit 107.1
CALCULATION OF FILING FEE TABLE
Form S-8
AN2 Therapeutics, Inc.
Table 1: Newly Registered Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Security Type |
| Security Title |
| Fee |
| Amount to be |
| Proposed |
| Proposed |
| Fee |
| Amount of |
|
|
|
|
|
|
|
| |||||||
Equity |
| Common Stock, $0.00001 par value per share, reserved for issuance pursuant to the Registrant’s 2022 Equity Incentive Plan |
| 457(c) and 457(h) |
| 1,189,657 (2) |
| $3.17 (4) |
| $3,771,212.69 |
| 0.0001476 |
| $556.64 |
|
|
|
|
|
|
|
| |||||||
Equity |
| Common Stock, $0.00001 par value per share, reserved for future issuance pursuant to the Registrant’s 2022 Employee Stock Purchase Plan |
| 457(c) and 457(h) |
| 297,414 (3) |
| $2.69 (5) |
| $801,382.02 |
| 0.0001476 |
| $118.29 |
|
|
|
|
| ||||||||||
Total Offering Amounts |
|
|
| $4,572,594.71 |
|
|
| $674.93 | ||||||
|
|
|
|
| ||||||||||
Total Fee Offsets |
|
|
|
|
|
|
| N/A | ||||||
|
|
|
|
| ||||||||||
Net Fee Due |
|
|
|
|
|
|
| $674.93 |